 | Cardiac Toxicity – drugs causing heart muscle, valve damage or potentially fatal arrhythmias in patients - has been implicated in 28% of drug withdrawals in the USA over the last 30 years.The significance for patients, regulators and the pharmaceutical industry is immense. If cardiac toxicity is discovered during a drug’s development the programme will, almost invariably, be terminated. If cardiac toxicity is discovered after launch then the drug may be withdrawn or new labelling will almost certainly be required. |
|
 | The Biopharm Outsourcing Register provides a fast, efficient, user-friendly solution to searching for a service organisation direct from your own desktop.Subscribers can search by single or multiple parameters to target quickly those companies best able to meet a specific outsourcing need. The Biopharm Outsourcing Register contains details of 1,400 organisations - the most comprehensive global database available:* Global CROs - Clinical Research, Data Management & Regulatory Affairs* Global CROs - Preclinical, Toxicology & Analysis* Global CMOs - Manufacturing Services |
|
| Understanding immunogenicity, a detrimental and potentially dangerous response to therapeutic proteins, is vitally important for the successful development and marketing of biotech drugs. Failure to predict and minimise levels of immunogenicity may have harmful and sometimes disastrous results for both patients and the industry. |
|
| A definitive report on the current status and future prospects of Central Clinical Pathology Laboratories, Central ECG Analysis Laboratories and Central Bio-imaging Laboratories. |
|
| A detailed guide to the factors that will shape this vital market, including company strategies, comparability, regulation, the implications for clinical trials and legal issues. With a chapter written by PricewaterhouseCoopers looking at the commercial implications for the biotech and pharmaceutical markets |
|
| Pharmaceutical and biotech companies are outsourcing more of their work than ever before – the list includes drug discovery, development, manufacture and marketing. This new report provides a clear, comprehensive guide to the processes involved in outsourcing chemical and biotech development and production. |
|
| The definitive guide:• Written by industry experts• Edited and produced by the leading outsourcing publisher and consultancy |
|
